Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases : Results From a Nordic Survey

Kapetanovic, Meliha LU ; Mandla, Randeep ; Gren, Susanne Thiesen ; Seddighzadeh, Maria ; Henrohn, Dan ; Palmroth, Maaria ; Hiltunen, Anna Maria ; Ranta, Jussi ; Asikainen, Anna Kaisa and Frøstrup, Anne Grete , et al. (2025) In Journal of Patient Experience 12.
Abstract

A survey on vaccinations was conducted among patients with chronic inflammatory diseases (CIDs), including inflammatory bowel disease, inflammatory rheumatological diseases, and dermatological diseases (DDs). The objective was to identify differences between established vaccination guidelines and actual practices in healthcare as experienced by patients. Among eligible responders (n = 1434), 57% were on immunomodulatory treatment, and 59% were treated in specialized care. The most recommended vaccines were COVID-19 (66%), influenza (63%), and pneumococcal (46%). Regarding common vaccination principles for patients with CID, 61% reported not receiving information on vaccinations before treatment initiation. Only 23% were advised to check... (More)

A survey on vaccinations was conducted among patients with chronic inflammatory diseases (CIDs), including inflammatory bowel disease, inflammatory rheumatological diseases, and dermatological diseases (DDs). The objective was to identify differences between established vaccination guidelines and actual practices in healthcare as experienced by patients. Among eligible responders (n = 1434), 57% were on immunomodulatory treatment, and 59% were treated in specialized care. The most recommended vaccines were COVID-19 (66%), influenza (63%), and pneumococcal (46%). Regarding common vaccination principles for patients with CID, 61% reported not receiving information on vaccinations before treatment initiation. Only 23% were advised to check their vaccination status before starting medications, and just 20% reported that their vaccination status is regularly assessed. Logistic regression revealed that the DD group was less likely, while patients over 65 years of age or on immunomodulatory treatment were more likely to be recommended and receive vaccinations. Ideally, all CID patients should be eligible for preventive immunization starting from the time of diagnosis. A targeted vaccination program with clear responsibilities across the healthcare system is strongly recommended.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
chronic inflammatory diseases, dermatology, immunosuppression, inflammatory bowel disease, patient survey, preventive care, rheumatology, vaccination
in
Journal of Patient Experience
volume
12
article number
23743735251360485
publisher
SAGE Publications
external identifiers
  • pmid:40727876
  • scopus:105012509525
ISSN
2374-3735
DOI
10.1177/23743735251360485
language
English
LU publication?
yes
id
b03eb8eb-8377-498d-a209-42b2cb1e2d10
date added to LUP
2026-01-14 14:19:41
date last changed
2026-05-07 06:37:00
@article{b03eb8eb-8377-498d-a209-42b2cb1e2d10,
  abstract     = {{<p>A survey on vaccinations was conducted among patients with chronic inflammatory diseases (CIDs), including inflammatory bowel disease, inflammatory rheumatological diseases, and dermatological diseases (DDs). The objective was to identify differences between established vaccination guidelines and actual practices in healthcare as experienced by patients. Among eligible responders (n = 1434), 57% were on immunomodulatory treatment, and 59% were treated in specialized care. The most recommended vaccines were COVID-19 (66%), influenza (63%), and pneumococcal (46%). Regarding common vaccination principles for patients with CID, 61% reported not receiving information on vaccinations before treatment initiation. Only 23% were advised to check their vaccination status before starting medications, and just 20% reported that their vaccination status is regularly assessed. Logistic regression revealed that the DD group was less likely, while patients over 65 years of age or on immunomodulatory treatment were more likely to be recommended and receive vaccinations. Ideally, all CID patients should be eligible for preventive immunization starting from the time of diagnosis. A targeted vaccination program with clear responsibilities across the healthcare system is strongly recommended.</p>}},
  author       = {{Kapetanovic, Meliha and Mandla, Randeep and Gren, Susanne Thiesen and Seddighzadeh, Maria and Henrohn, Dan and Palmroth, Maaria and Hiltunen, Anna Maria and Ranta, Jussi and Asikainen, Anna Kaisa and Frøstrup, Anne Grete and Anttila, Veli Jukka}},
  issn         = {{2374-3735}},
  keywords     = {{chronic inflammatory diseases; dermatology; immunosuppression; inflammatory bowel disease; patient survey; preventive care; rheumatology; vaccination}},
  language     = {{eng}},
  month        = {{01}},
  publisher    = {{SAGE Publications}},
  series       = {{Journal of Patient Experience}},
  title        = {{Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases : Results From a Nordic Survey}},
  url          = {{http://dx.doi.org/10.1177/23743735251360485}},
  doi          = {{10.1177/23743735251360485}},
  volume       = {{12}},
  year         = {{2025}},
}